These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9473378)

  • 1. Properties of human anti-group B streptococcal type III capsular IgG antibody.
    Feldman RG; Breukels MA; David S; Rijkers GT
    Clin Immunol Immunopathol; 1998 Feb; 86(2):161-9. PubMed ID: 9473378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid-phase antigen density and avidity of antibodies detected in anti-group B streptococcal type III IgG enzyme immunoassays.
    Feldman RG; Hamel ME; Breukels MA; Concepcion NF; Anthony BF
    J Immunol Methods; 1994 Mar; 170(1):37-45. PubMed ID: 7512607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type III group B Streptococcus: functional interaction with IgG subclass antibodies.
    Givner LB; Baker CJ; Edwards MS
    J Infect Dis; 1987 Mar; 155(3):532-9. PubMed ID: 3543156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation of in vitro opsonic activity of human antibody induced by a vaccine consisting of the type III-specific polysaccharide of group B streptococcus.
    De Cueninck BJ; Eisenstein TK; McIntosh TS; Shockman GD; Swenson RM
    Infect Immun; 1983 Mar; 39(3):1155-60. PubMed ID: 6341229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lectin site interaction with capsular polysaccharide mediates nonimmune phagocytosis of type III group B streptococci.
    Albanyan EA; Edwards MS
    Infect Immun; 2000 Oct; 68(10):5794-802. PubMed ID: 10992487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional activity of class-specific antibodies to type III, group B streptococcus.
    Campbell JR; Baker CJ; Metzger TG; Edwards MS
    Pediatr Res; 1988 Jan; 23(1):31-4. PubMed ID: 3277150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pooled human IgG hyperimmune for type III group B streptococci: evaluation against multiple strains in vitro and in experimental disease.
    Givner LB; Baker CJ
    J Infect Dis; 1991 May; 163(5):1141-5. PubMed ID: 2019763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The group B streptococcal capsular carbohydrate: immune response and molecular mimicry.
    Feldman RG; Rijkers GT; Hamel ME; David S; Zegers BJ
    Adv Exp Med Biol; 1998; 435():261-9. PubMed ID: 9498084
    [No Abstract]   [Full Text] [Related]  

  • 9. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.
    Kasper DL; Paoletti LC; Wessels MR; Guttormsen HK; Carey VJ; Jennings HJ; Baker CJ
    J Clin Invest; 1996 Nov; 98(10):2308-14. PubMed ID: 8941648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opsonic activity of human IgG and IgM antibody for type III group B streptococci.
    Anthony BF; Concepcion NF
    Pediatr Res; 1989 Oct; 26(4):383-7. PubMed ID: 2677951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the opsonic and complement triggering activity of human monoclonal IgG1 and IgM antibody against group B streptococci.
    Shyur SD; Raff HV; Bohnsack JF; Kelsey DK; Hill HR
    J Immunol; 1992 Mar; 148(6):1879-84. PubMed ID: 1541826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired phagocytosis and opsonisation towards group B streptococci in preterm neonates.
    Källman J; Schollin J; Schalèn C; Erlandsson A; Kihlström E
    Arch Dis Child Fetal Neonatal Ed; 1998 Jan; 78(1):F46-50. PubMed ID: 9536841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative functional activity of purified human immunoglobulin G against a type III group B streptococcal strain.
    Kim KS; Kang JH; Concepcion NF; Anthony BF
    Infect Immun; 1986 Jun; 52(3):908-10. PubMed ID: 3519467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 Is Associated With Lower Group B Streptococcus Capsular and Surface-Protein IgG Antibody Levels and Reduced Transplacental Antibody Transfer in Pregnant Women.
    Dangor Z; Kwatra G; Izu A; Adrian P; van Niekerk N; Cutland CL; Adam Y; Velaphi S; Lala SG; Madhi SA
    J Infect Dis; 2015 Aug; 212(3):453-62. PubMed ID: 25651843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of functional activities between IgG1 and IgM class-switched human monoclonal antibodies reactive with group B streptococci or Escherichia coli K1.
    Raff HV; Bradley C; Brady W; Donaldson K; Lipsich L; Maloney G; Shuford W; Walls M; Ward P; Wolff E
    J Infect Dis; 1991 Feb; 163(2):346-54. PubMed ID: 1988519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type-specific monoclonal antibody enhances the local phagocytic response to group B streptococcal infection.
    Shigeoka AO; Weber ME; Pincus SH; Pritchard DG; Egan ML; Hill HR
    J Infect Dis; 1986 Jun; 153(6):1170-3. PubMed ID: 3517190
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of cross-reactive antibodies with low opsonophagocytic activity for Streptococcus pneumoniae.
    Nahm MH; Olander JV; Magyarlaki M
    J Infect Dis; 1997 Sep; 176(3):698-703. PubMed ID: 9291318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human B lymphocyte in vitro response to the group B streptococcal type III capsular carbohydrate.
    Feldman RG; Rijkers GT; Zegers BJ
    Scand J Immunol; 1993 Mar; 37(3):343-8. PubMed ID: 8441921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methods of assessment and importance of opsonic activity for GBS.
    Hill HR; Shigeoka AO; Rote NS; Allred CD; Hemming VG
    Antibiot Chemother (1971); 1985; 35():157-69. PubMed ID: 3901892
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of an opsonin inhibition assay for evaluation of complex polysaccharide protective epitopes.
    McNeely T; Luo S; Manger W; Herber W; Schofield T; Tan C; Newman K; Sadoff J; Donnelly J; Cross A
    Vaccine; 2006 Mar; 24(11):1941-8. PubMed ID: 16307833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.